Condition: Diabetic Foot Ulcer (DFU) · Chronic Foot Ulcers · Sponsor: Tides Medical
The purpose of this clinical investigation is to evaluate the safety and efficacy of Amnion/Chorion/Amnion allograft , Amnion/Chorion allograft, and/or Amnion/Amnion allograft, plus Standard of Care (SOC) each versus SOC alone in the treatment of chronic non-healing diabetic foot ulcers (DFU) after 12 weeks of treatment.
This description comes directly from the study's public registry record.
Frank Burrows III, MBA, EMT, BCMAS, CWCA · 888-494-4441 · FBurrows@tidesmedical.com
Mora Melican, PH.D. · 888-494-4441 · MMelican@tidesmedical.com
Always discuss trial participation with your own doctor first.
| Limb Preservation Platform Inc | Fresno, California, United States | Recruiting |
| Angel City Research | Los Angeles, California, United States | Recruiting |
| Clemente Clinical Research | Los Angeles, California, United States | Recruiting |
| ILD Research Center | Vista, California, United States | Recruiting |
| Clever Medical Research | Miami, Florida, United States | Recruiting |
| Foot and Ankle Specialists of the Mid-Atlantic | Raleigh, North Carolina, United States | Recruiting |
| Lower Extremity Institute of Research and Therapy | Boardman, Ohio, United States | Recruiting |
| Brock Liden DPM | Circleville, Ohio, United States | Recruiting |
| Foot and Ankle Specialists of the Mid-Atlantic | Salem, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06681428